Obesity has been described as a protective factor in cardiovascular and other diseases being expressed as 'obesity paradox'. However, the impact of obesity on clinical outcomes including mortality in COVID-19 has been poorly systematically investigated until now. We aimed to compare clinical outcomes among COVID-19 patients divided into three groups according to the body mass index (BMI).
Abumayyaleh M, Núñez Gil IJ, El-Battrawy I, Estrada V, Becerra-Muñoz VM, Aparisi A, Fernández-Rozas I, Feltes G, Arroyo-Espliguero R, Trabattoni D, López-País J, Pepe M, Romero R, García DRV, Biole C, Astrua TC, Eid CM, Alfonso E, Fernandez-Presa L, Espejo C, Buonsenso D, Raposeiras S, Fernández C, Macaya C, Akin I; HOPE COVID-19 investigators. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry. Obes Res Clin Pr 2021 Mar 3;S1871-403X(21)00034-X. doi: 10.1016/j.orcp.2021.02.008.